Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions
- PMID: 14512803
- DOI: 10.1097/00008469-200310000-00007
Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions
Abstract
We investigated clinical efficacy of green tea extracts (polyphenon E; poly E and (-)-epigallocatechin-3-gallate [EGCG]) delivered in a form of ointment or capsule in patients with human papilloma virus (HPV) infected cervical lesions. Fifty-one patients with cervical lesions (chronic cervicitis, mild dysplasia, moderate dysplasia and severe dysplasia) were divided into four groups, as compared with 39 untreated patients as a control. Poly E ointment was applied locally to 27 patients twice a week. For oral delivery, a 200 mg of poly E or EGCG capsule was taken orally every day for eight to 12 weeks. In the study, 20 out of 27 patients (74%) under poly E ointment therapy showed a response. Six out of eight patients under poly E ointment plus poly E capsule therapy (75%) showed a response, and three out of six patients (50%) under poly E capsule therapy showed a response. Six out of 10 patients (60%) under EGCG capsule therapy showed a response. Overall, a 69% response rate (35/51) was noted for treatment with green tea extracts, as compared with a 10% response rate (4/39) in untreated controls (P<0.05). Thus, the data collected here demonstrated that green tea extracts in a form of ointment and capsule are effective for treating cervical lesions, suggesting that green tea extracts can be a potential therapy regimen for patients with HPV infected cervical lesions.
Similar articles
-
Effects of the Green Tea Polyphenol Epigallocatechin-3-Gallate on Glioma: A Critical Evaluation of the Literature.Nutr Cancer. 2018 Apr;70(3):317-333. doi: 10.1080/01635581.2018.1446090. Epub 2018 Mar 23. Nutr Cancer. 2018. PMID: 29570984 Review.
-
An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in treatment of pancreatic cancer.Recenti Prog Med. 2017 Jun;108(6):282-287. doi: 10.1701/2715.27715. Recenti Prog Med. 2017. PMID: 28631776 Review. English.
-
Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia.Gynecol Oncol. 2014 Feb;132(2):377-82. doi: 10.1016/j.ygyno.2013.12.034. Epub 2014 Jan 2. Gynecol Oncol. 2014. PMID: 24388920 Free PMC article. Clinical Trial.
-
Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.Clin Cancer Res. 2005 Jun 15;11(12):4627-33. doi: 10.1158/1078-0432.CCR-04-2549. Clin Cancer Res. 2005. PMID: 15958649 Clinical Trial.
-
Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.Clin Cancer Res. 2003 Aug 15;9(9):3312-9. Clin Cancer Res. 2003. PMID: 12960117 Clinical Trial.
Cited by
-
Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies.Cancers (Basel). 2024 Jan 17;16(2):399. doi: 10.3390/cancers16020399. Cancers (Basel). 2024. PMID: 38254888 Free PMC article. Review.
-
Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: the role of genes, MicroRNA and DNA methylation patterns.Cancer Cell Int. 2023 Dec 21;23(1):335. doi: 10.1186/s12935-023-03161-9. Cancer Cell Int. 2023. PMID: 38129839 Free PMC article. Review.
-
Bioactive nutraceuticals as G4 stabilizers: potential cancer prevention and therapy-a critical review.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3585-3616. doi: 10.1007/s00210-023-02857-z. Epub 2023 Nov 29. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38019298 Review.
-
Preventing Persistence of HPV Infection with Natural Molecules.Pathogens. 2023 Mar 6;12(3):416. doi: 10.3390/pathogens12030416. Pathogens. 2023. PMID: 36986338 Free PMC article. Review.
-
The Association of Four Natural Molecules-EGCG, Folic Acid, Vitamin B12, and HA-To Counteract HPV Cervical Lesions: A Case Report.J Pers Med. 2023 Mar 22;13(3):567. doi: 10.3390/jpm13030567. J Pers Med. 2023. PMID: 36983748 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical